Key facts
- A new pancreatic cancer treatment has shown success in late-stage trials.
- The treatment nearly doubles survival rates for patients with pancreatic cancer.
- The announcement received a standing ovation from doctors and oncology professionals.
Pancreatic cancer is one of the deadliest forms of cancer, with historically low survival rates. The development of a treatment that significantly improves survival is a major breakthrough in oncology.